• Flatiron Health Pioneers International Patient-Level Data Sharing for Oncology Research

    Clinical Research News | Flatiron Health is breaking new ground in oncology research by enabling patient-level real-world data (RWD) sharing across four countries—U.S., UK, Germany, and Japan. Despite initial skepticism, researchers are now eager to access these harmonized electronic health record (EHR) datasets in a secure, cloud-based environment.

    Mar 20, 2025

  • AI Platform Aims to Translate Trial Results at the Point of Care

    Clinical Research News | For medical oncologists, the clinical quandary in treating patients is whether a newly marketed agent or drug cocktail will work as well as it did for the average cancer patient in a landmark clinical trial.

    Mar 18, 2025

  • Navigating the Real-World: How to Better Utilize Real-World Evidence

    Clinical Research News | Interest in Real-World Evidence (RWE) studies continues to grow. Data from ClinicalTrials.gov shows the number of RWE studies registered has increased dramatically since 2005, particularly in the last seven years. But what is RWE, how is it used in clinical trials and how can we work with Real-World Data (RWD) to produce RWE?

    Mar 14, 2025

  • Jumo Health Broadening its Health Equity Approach

    Clinical Research News | Jumo Health launched a suite of services to drive health equity in clinical trials in 2023 via a collaboration with I Choose Life Foundation, a nonprofit dedicated to addressing health disparities in the African American community. It helped the company pilot its first community engagement event in the form of a workshop to train local business and faith leaders to serve as trusted messengers of information about clinical research and the point-of-care experience.

    Mar 12, 2025

  • Black Women with Breast Cancer Now Lead Champions of Clinical Trials

    Clinical Research News | For Black women diagnosed with breast cancer, the grim reality is that they are 41% more likely to die of the disease than white women. African American women are disproportionately affected by triple negative breast cancer (TNBC), the most aggressive form of the disease, but that only partially explains the discrepancy in the mortality rate.

    Mar 11, 2025

  • The Scope of Things: Sharing Patient Insights, Absence of Pregnant Women in Clinical Trials, Boosting Cancer Vaccine Work, More

    Clinical Research News | In this month’s episode of the Scope of Things, host Deborah Borfitz delivers the news on how an AI-powered trial screening tool outperformed human research staff, a strategy report on boosting cancer vaccine work, the issue of continued absence of pregnant women in clinical trials, and more. Plus, Rare Patient Voice founder and president Wes Michael also joins in to talk about how his company is connecting people undertaking research studies with participants eager to share their insights.

    Mar 6, 2025

  • AstraZeneca Scaling Up Use of Generative AI to Help Reach 2030 Ambitions

    Clinical Research News | Generative artificial intelligence is being used by AstraZeneca to expedite its five-year ambitions to be an $80 billion company, deliver 20 new medicines, and be carbon negative. The initial value-driving activities include the creation of AI assistants to help with 3D location detection on CT scans and facilitate knowledge extraction for clinical documents as well as an intelligent protocol tool built in partnership with medical writers.

    Feb 4, 2025